Intellia Therapeutics Inc (NTLA)
A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.
2/100
Low signalSIGNAL SCORE
P(beat S&P 500 · next 20 sessions)43%
Our last 30 days of resolved calls came true 33% of the time.See the track record →
Price
$12.37
1 day
-2.98%
1 week
+5.99%
1 month
+5.72%
1 year
-36.12%
Market cap
$1.7B
Company fundamentals
EPS (TTM)
$-3.36
Debt / Equity
0.00
Current ratio
6.65
Operating margin
-711.7%
Net margin
-672.2%
Return on equity
-57.8%
Revenue growth (YoY)
12.6%
Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.
Example trade plan · illustrative risk framework
Entry zone
$12.18–$12.62
Stop-loss (exit)
$11.13 −10%
Target (exit)
$14.84 +20%
A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.
Why it ranks: factor attribution
- Weekly momentum+6.0% over the past week+6
- QualityRevenue growing 13% y/y-4
- VolumeNo intraday volume on the free data tier — this factor is disabled, not faked.+0
Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →